Kevin O'Boyle

Kevin O'Boyle

Director/Board Member bei NEVRO CORP.

Vermögen: 352 603 $ am 31.03.2024

68 Jahre
Health Technology
Finance
Consumer Services

Profil

Kevin C.
O'Boyle
currently works at Nevro Corp., as Independent Director from 2019, San Diego Hall of Champions, as Director, ChromaCode, Inc., as Director from 2021, HighCape Partners Management LLC, as Advisor, and HighCape Capital Acquisition Corp.
II, as Advisor from 2020.
Mr. O'Boyle also formerly worked at GenMark Diagnostics, Inc., as Chairman from 2020 to 2021, NeoTract, Inc., as Director in 2017, ZELTIQ Aesthetics, Inc., as Independent Director from 2011 to 2017, Tornier NV, as Independent Non-Executive Director from 2013 to 2019, Sientra, Inc., as Independent Director from 2014 to 2023, Durata Therapeutics, Inc., as Independent Director from 2012 to 2014, Wright Medical Group NV, as Independent Non-Executive Director from 2010 to 2020, Clarient, Inc., as Chief Financial Officer & Senior VP-Operations, NuVasive, Inc., as Chief Financial Officer from 2003 to 2009, Chroma Vision Medical Systems, Inc., as Chief Financial & Operating Officer, Shire Regenerative Medicine, Inc., as Chief Financial Officer & Senior Vice President from 2010 to 2011, Albert Fisher Group Plc, as Chief Financial Officer & SVP-Operations, Albert Fisher North America, Inc., as Chief Financial Officer & SVP-Operations, American Cablesystems Corp., as Vice President & Controller, and HighCape Capital Acquisition Corp., as Advisor.
Mr. O'Boyle received his undergraduate degree from Rochester Institute of Technology.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
25.05.2023 24 227 ( 0,07% ) 349 838 $ 31.03.2024
31.03.2023 11 767 ( 0,10% ) 2 765 $ 31.03.2024

Aktive Positionen von Kevin O'Boyle

UnternehmenPositionBeginn
NEVRO CORP. Director/Board Member 19.03.2019
Director/Board Member 11.08.2021
Corporate Officer/Principal 01.05.2020
San Diego Hall of Champions Director/Board Member 21.03.2011
Consultant / Advisor -
Alle aktiven Positionen von Kevin O'Boyle

Ehemalige bekannte Positionen von Kevin O'Boyle

UnternehmenPositionEnde
SIENTRA, INC. Director/Board Member 15.06.2023
GENMARK DIAGNOSTICS, INC. Chairman 22.04.2021
WRIGHT MEDICAL GROUP N.V. Director/Board Member 11.11.2020
Director/Board Member 29.03.2019
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Kevin O'Boyle im Detail an

Ausbildung von Kevin O'Boyle

Rochester Institute of Technology Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Kevin O'Boyle im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

21

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
SIENTRA, INC.

Health Technology

NEVRO CORP.

Health Technology

Private Unternehmen18

Health Services

Health Technology

Chroma Vision Medical Systems, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Albert Fisher Group Plc

Distribution Services

Health Technology

Albert Fisher North America, Inc.

Consumer Services

San Diego Hall of Champions

Finance

Health Technology

Technology Services

Finance

Finance

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Kevin O'Boyle